Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Hideki Furuya PhD, MS

Hideki Furuya PhD, MS

Assistant Professor, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California

Hideki Furuya, PhD, is Assistant Professor at Cedars-Sinai Medical Center. He received his undergraduate education at Meiji University in Japan. He earned his PhD from Meiji University in Japan in 2009 and following this he started his postdoctoral training at Medical University of South Carolina and University of Hawaii Cancer Center. He became a faculty at University of Hawaii Cancer Center in 2015, and then joined Cedars-Sinai Medical Center in 2019. Dr. Furuya conducts research focused on developing novel therapies and diagnostic tests for bladder cancer, with a particular interest in urine-based multiplex assays for bladder cancer detection, monitoring, and prediction to treatments including chemotherapy and immunotherapy.

Disclosures

No disclosures reported.

Recent Contributions to PracticeUpdate:

  1. The BlaDimiR Assay for Bladder Cancer Diagnosis